Developing biosimilar monoclonal antibodies will not be easy Interviewee/Contributor Gabriele Schaffner-Dallmann Organisation Pharmatching GmbH Antibody Biosimilar medicine Policy & Regulation Read more about Developing biosimilar monoclonal antibodies will not be easy